Robert Zeillinger

ORCID: 0000-0001-6771-4591 · 12 papers in corpus
observational 2025
Life (Basel, Switzerland) ·doi:10.3390/life15020135

BACKGROUND: Cervical cancer (CC) is the fourth most common cancer diagnosis in women worldwide. Infection with high-risk human papillomavirus (HPV) is a critical but not determinative condition for CC development, as several co-factors modu…

observational 2024
Biomedicines ·doi:10.3390/biomedicines12020321

Interleukin-8 (IL-8) is involved in the regulation of inflammatory processes and carcinogenesis. Single-nucleotide polymorphisms (SNPs) within the IL-8 gene have been shown to alter the risks of lung, gastric, or hepatocellular carcinomas. …

observational 2024
International journal of molecular sciences ·doi:10.3390/ijms251910272

Single nucleotide polymorphisms (SNPs) of the IL-16 gene have been reported to influence the risk of several cancers, but their role in ovarian cancer (OC) has not been studied. Using the restriction fragment length polymorphism (PCR-RFLP) …

diagnostic-accuracy 2022
Cancers ·doi:10.3390/cancers14071780

Ovarian cancer (OC) is the most lethal genital malignancy in women. We aimed to develop and validate new proteomic-based models for non-invasive diagnosis of OC. We also compared them to the modified Risk of Ovarian Malignancy Algorithm (RO…

other 2019
Cell reports ·doi:10.1016/j.celrep.2019.05.109

High-accuracy next-generation DNA sequencing promises a paradigm shift in early cancer detection by enabling the identification of mutant cancer molecules in minimally invasive body fluid samples. We demonstrate 80% sensitivity for ovarian …

observational 2017
Oncology letters ·doi:10.3892/ol.2017.5969

17β-estradiol (E2) can contribute to the progression of epithelial ovarian cancer (EOC). Although the majority of patients with EOC are postmenopausal woman, when de novo estrogen production in the ovary has ceased, ovarian cancer cells rem…

other 2015
Journal of Clinical Oncology ·doi:10.1200/jco.2015.61.3083

PURPOSE: Type II ovarian cancer (OC) and endometrial cancer (EC) are generally diagnosed at an advanced stage, translating into a poor survival rate. There is increasing evidence that Müllerian duct cancers may exfoliate cells. We have esta…

diagnostic-accuracy 2013
BMC cancer ·doi:10.1186/1471-2407-13-178

BACKGROUND: The immune system is a key player in fighting cancer. Thus, we sought to identify a molecular 'immune response signature' indicating the presence of epithelial ovarian cancer (EOC) and to combine this with a serum protein biomar…

review 2013
Journal of drug delivery ·doi:10.1155/2013/957605

The extragonadal synthesis of biological active steroid hormones from their inactive precursors in target tissues is named "intracrinology." Of particular importance for the progression of estrogen-dependent cancers is the in situ formation…

observational 2002
Journal of the Society for Gynecologic Investigation ·doi:10.1016/s1071-5576(02)00174-0

To explore whether having the mutant tumor necrosis factor (TNF)2 (G-308*A) and TNFA-A (G-238*A) alleles in the TNF-alpha gene promotor region is higher in women with endometriosis, we determined the respective genotype and allele frequenci…

2002
·doi:10.1177/107155760200900510
diagnostic-accuracy 1998
British journal of cancer ·doi:10.1038/bjc.1998.311

As a promoter of angiogenesis, vascular endothelial growth factor (VEGF) is believed to play a pivotal role in tumour growth and metastasis. The aim of this study was to determine the value of preoperative serum VEGF levels in the early dia…